The role of basophils and mast cells in acute and late reactions in the skin

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue SUPPL. 34, 1997, Pages 31-43

  Charlesworth, Ernest N ^a  

^a Brenham Clinic   (United States)

Author keywords

Allergic diseases; Antigen; Basophils; Mast cells

Indexed keywords

CETIRIZINE; CHLORPHENIRAMINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 6; MAJOR BASIC PROTEIN; PROMETHAZINE;

BASOPHIL; HUMAN; MAST CELL; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY;

ANIMALS; BASOPHILS; EOSINOPHILS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION MEDIATORS; LYMPHOCYTES; MAST CELLS; MICE; NEUTROPHILS; RESPIRATORY HYPERSENSITIVITY; SKIN;

EID: 0031009395     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb04809.x     Document Type: Article

References (73)

1. Blackley CH. Hay fever: its causes, treatment, and effective prevention. In: Experimental Researches. 2nd ed. London: Tindall and Cox, Ltd, 1873;77-89.
2. Cooke RA. Studies in specific hypersensitiveness. IX. On the phenomenon of hypersensitization (the clinically lessened sensitiveness of allergy). J Immunol 1922;6:219-42.
3. Pepys J. Hypersensitivity diseases of the lung due to fungi and organic dust. In: Kallos P, Inderbitzin TM, Miescher PA, Waksman BH, eds. Monographs in Allergy. Vol IV. Basel: S. Kauger, 1969:22-68.
4. Dolovich J, Hargreave FE, Chalmers R, et al. Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol 1973;52:38-46.
5. Solley GO, Gleich GJ, Jordon RE, et al. Late phase of the immediate wheal and flare skin reactions. Its dependence on IgE antibodies. J Clin Invest 1976;58:408-20.
6. Hexheimer H. The late bronchial reaction in induced asthma. Int Arch Allergy Appi Immunol 1952;3:323-7.
7. Robertson DG, Kerigan AT, Hargreave FE, et al. Late asthmatic responses induced by ragweed pollen allergen. J Allergy 1974;54:244-54.
8. Warner JO, Soothill JF, Price JF, et al. Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978:912-7.
9. Cartier A, Thompson NC, Frith PA, et al. Allergen induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 1982;70:170-7.
10. Atkins P, Green GR, Zweiman B. Histologic studies of human skin test responses to ragweed, compound 48/80 and histamine. J Allergy Clin Immunol 1973;51:263-73.
11. Soter NA, Lewis RA, Corey EJ, et al. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4 and LTB4) in human skin. J Invest Dermatol 1983;80:115-9.
12. Basran GS, Page CP, Paul W, et al. Platelet-activating factor: a possible mediator of the dual response to allergen? Clin Allergy 1984;14:75-9.
13. Michel L, Mencia-Huerta J, Benveniste J, et al. Biologic properties of LTB4 and PAF-acether in vivo in human skin. J Invest Dermatol 1987;88:675-81.
14. Henocq E, Vargaftig BB. Skin eosinophilia in atopic subjects. J Allergy Clin Immunol 1988;81:691-5.
15. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:1013-26.
16. Weiss M, Fisher RH, Kagey-Sobotka A, et al. In vivo response to platelet derived histamine releasing factor. J Allergy Clin Immunol 1988;81:224.
17. Dvorak AM, Ishizaka T, Galli SX Ultrastructure of human basophils developing in vitro. Evidence for the acquisition of peroxidase by basophils and for different effects of human and murine growth factors on basophil and eosinophil maturation. Lab Invest 1985;538:57-71.
18. Denburg JA, Richardson M, Telizyn S, Bienenstock J. Basophil/lung mast cell precursors in human peripheral blood. Blood 1983;61:775-80.
19. Kitamura Y, Nakayama H, Fujita J. Mechanism of mast cell deficiency in mutant mice of the W/Wv and SI/SId genotype. In: Galli SJ, Austen KF, eds. Mast cell and basophil differentiation and function in health and disease. New York: Raven Press, 1989:15-25.
20. Toth-Kasa I, Jancso G, Obal F, Husz S, Simon N. Involvement of sensory nerve endings in cold and heat urticaria. J Invest Dermatol 1983;80:34-6.
21. Benyon RC. Review: the human skin mast cell. Clin Exper Allergy 1989;19:375-87.
22. Schwartz LB, Irani AM, Roller K, Castells M, SchechterNM. Quantitation of histamine, tryptase, and chymase in dispersed human T and CT mast cells. J Immunol 1987;138:2611-5.
23. Holgate ST, Burns GB, Robinson C, et al. Anaphylactic and calcium dependent generation of prostaglandin D2 (PGD2), thromboxane B2 and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J Immunol 1984;133:2138.
24. Lawrence ID, Warner JA, Cohan VL, et al. Purification and characterization of human skin mast cells: evidence of human mast cell herogeneity. J Immunol 1987;139:3062-9.
25. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985;313:65-70.
26. Robinson C, Benyon C, Holgate St, et al. The IgE and calcium dependent release of eicosanoids and histamine from human purified cutaneous mast cells. J Invest Dermatol 1989;93:397-404.
27. Thomas G, Church MK. Platelet activating factor does not release histamine from human dispersed cutaneous mast cells. Clin Exp Allergy 1990;90:377-82.
28. Casolaro V, Galeone D, Giacummo A, et al. Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma and from bronchoalveolar lavage in asthmatic. Am Rev Respir Dis 1989;139:1375-82.
29. Casolaro V, Spadaro G, Marone G. Human basophil releasability VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis 1990;142:1108-11.
30. Marone G, Giugliano R, Lembo G, Ayala F. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. J Invest Dermatol 1986;87:19-23.
31. Schleimer RP, Schulman ES, MacGlashan DW, et al. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest 1983;71:1830-5.
32. Peters SP, Naclerio RM, Schleimer RP, et al. The pharmacologic control of mediator release from human basophils and mast cells. Respiration 1986;50:116-22.
33. Leiferman KM, Gleich GJ, Kephart GM, et al. Differences between basophils and mast cells: Failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells. J Immunol 1986;136:852-5.
34. Blank IH, Miller OG. A method for the separation of the epidermis from the dermis. J Invest Dermatol 1950;15:9-10.
35. Kiistala U, Mustakallio KK. Dermato-epidermal separation with suction. Electron microscopy and histochemical study of initial events of blistering on human skin. J Invest Dermatol 1967;48:466-77.
36. Ting S, Dunsky EH, Lavker RM, et al. Patterns of mast cell alterations and in vivo mediator release in human allergic skin reactions. J Allergy Clin Immunol 1980;66:417-23.
37. Zweiman B, Kornstein M, Atkins P. Immunohistologic studies of late cutaneous allergic reactions. J Allergy Clin Immunol 1987;79:169 (abstract).
38. Charlesworth EN, Hood AF, Soter NA, et al. Cutaneous late-phase response to allergen: mediator release and inflammatory cell infiltration. J Clin Invest 1989;83:1519-26.
39. Wershil BK, Wang Zhen-Sheng, Gordon JT, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. J Clin Invest 1991;87:446-53.
40. Leiferman KM, Fujisawa T, Gray BH, Gleich GJ. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction. Lab Invest 1990;62:579-89.
41. Zweiman B, Atkins PC, von Allemn C, Gleich GJ. Release of eosinophil granule proteins during IgE-mediated allergic skin reactions. J Clin Invest 1991;87:984-92.
42. Frew AJ, Varney VA, Gaga M, Kay AB. Immunohistology of human allergic late-phase skin reactions. Skin Pharmacology 1991;(4 suppl) 1:71-8.
43. Weller PF, Lee CW, Fost DW, et al. Generation and metabolism of 5-lipoxygenase pathway leukotriene by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci USA 1983;80:7626-30.
44. Weiman B. Immunohistologic studies of late cutaneous allergic response in humans. I. Kinetics of histamine release. J Allergy Clin Immunol 1984;74:819-26.
45. Shalit M, Schwartz LB, Golzar N, et al. Release of histamine and tryptase in vivo after prolonged cutaneous challenge with allergen in humans. J Immunol 1988;141:821-6.
46. Talbot SF, Atkins PC, Goetzl EJ, et al. Accumulation of leukotriene C4 and histamine in human allergic skin reactions. J Clin Invest 1985;76:650-6.
47. Shalit M, Valone FH, Atkins PC, et al. Late appearance of phospholipid plate-activating factor and leukotriene B4 in human skin after repeated antigen challenge. J Allergy Clin Immunol 1989;85:691-6.
48. Tarawa N, Agrawal DK, Suliaman, et al. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun 1987;142:638-44.
49. Chilton FH, Connell TR. l-0-alkyl-2-arachidonoyl-sn-glycero-3- phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J Biol Chem 1984;259:12014-9.
50. Bochner BS, Charlesworth EN, Kagey-Sobotka, et al. Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol 1990;86:830-9.
51. Schleimer RP, Rutledge BK. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol esters. J Immunol 1986;135:649-54.
52. Bevilaqua MP, Pober DL, Mendrick, et al. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987;9238-42.
53. Subramanian N, Bray MA. Interleukin 1 releases histamine from human basophils and mast cells in vitro. J Immunol 1987;138:271-5.
54. Haak-Frendscho M, Dinarello CA, Kaplin AP, et al. Recombinant human interleukin 1 beta causes mstamine release from human basophils. J Allergy Clin Immunol 1988;82:218-23.
55. Lee CE, Neuland ME, Teaford HG, et al. Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals. J Allergy Clin Immunol 1992;89:1010-20.
56. Moller A, Lippert U, Lessmann D, et al. Human mast cells produce IL-8. J Immunol 1993;151:3261-6.
57. Bradding P, Feather IH, Wilson S, et al. Immunolocaliza-tion of cytokines in the nasal mucosa of normal and perennial rhinitic subjects: The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 1993;151:3853-65.
58. Morris FM, Whisman BA, Charlesworth EN. Measurement of TNF-α, GM- CSF, & IL-4 in the cutaneous late-phase response to antigen. J Allergy Clin Immunol 1994;93:261 (abstract#593).
59. Massey W, Friedman B, Kato M, et al. Appearance of granulocytes- macrophage colony stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites. J Immunol 1993;150:1084-92.
60. Varney VA, Hamid QA, Gaga M, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-51.
61. Robinson DS, Hamid Q, Ymg S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298.
62. Leung DYM, Pober JA, Cotran RS. Expression of endothe-lial-leukocytes adhesion molecule-1 in elicited late phase allergic reactions. J Clin Invest 1991;87:1805-9.
63. Klein LM, Lavker RM, Matis WL, et al. Degranulation of human mast cells induces an endothelial antigen central to leukocytes adhesion. Proc Natl Acad Sci USA 1989;86: 8972-6.
64. Gundel RH, Letts LG, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hyper responsiveness in primates. J Clin Invest 1991;87:1470.
65. Bochner BS, Luscinskas FW, Gimbrone MA, et al. Adhesion of human basophils, eosinophils and neutrophils to interleukin-1 activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553.
66. Weller PF, Rand TH, Goelz SE, et al. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88:7430.
67. Walsh GM, Mermod JJ, Hartnell A, Kay AB, et al. Human eosinophil, but not neutrophil, adherence to IL-1 stimulated human umbilical vascular endothelial cells is alpha4beta1 (very late antigen-4) dependent. J Immunol 1991;146:3419.
68. Pipkorn U, Proud D, Lichtenstein LM, et al. Effect of short-term glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 1987;80: 957-61.
69. Charlesworth EN, Kagey-Sobotka A, Schleimer RP, et al. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol 1991;146:671-6.
70. Schleimer RP, Lichtenstein LM, Gillespie E. Inhibition of basophil histamine release by anti-inflammatory steroids. Nature 19;292:454-55.
71. Fadel R, Herpin-Richard N, Rihoux JP, Henolg E. Inhibitory effect of cetirizine 2 HCL on eosinophilia in vivo. Clin Allergy 1987;17:373-6.
72. Charlesworth EN, Massey WA, Kagey-Sobotka A, et al. Effect of HI receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992;262:964-70.
73. Alam R, Dejarnatt A, Stafford S, et al. Selective inhibition of the cutaneous late, but not immediate, allergic response to antigens by misoprostol, a PGE analog. Am Rev Respir Dis 1993;148:1066-70.